Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02508662 · ClinicalTrials.gov registry record
Registry Study for Personalized Cancer Therapy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 5
- Enrollment target
NCT02508662: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02508662 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02508662 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Objectives: Primary Objectives: To evaluate the anti-cancer activity of commercially available, targeted anti-cancer therapies used off-label for treatment in patients with advanced solid cancer with known genomic aberrations. Secondary Objectives: To determine outcomes of patients who were treated with matched targeted anti-cancer therapies based on known genomic aberrations. To obtain treatment related adverse events in patients with advanced solid tumor who were treated with off -label targeted therapies. To determine co-genomic aberrations that may contribute to treatment response or resistance mechanisms. To determine feasibility of detecting the genomic alterations in plasma, and the genomic evolution of circulating biomarkers.
Interventions
- OTHER Review of Screening Tests and Molecular Test Results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-07-21 |
| Est. Completion | 2020-07-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02508662
The ClinicalTrials.gov registry entry for NCT02508662 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Review of Screening Tests and Molecular Test Results is the first listed.
NCT02508662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02508662 about?
NCT02508662 is a clinical study titled "Registry Study for Personalized Cancer Therapy". Objectives: Primary Objectives: To evaluate the anti-cancer activity of commercially available, targeted anti-cancer therapies used off-label for treatment in patients with advanced solid cancer with known genomic aberrations. Secondary Objectives: To determine outcomes of patients who were trea...
What is the current status of trial NCT02508662?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2015-07-21. Estimated completion is 2020-07-10.
What interventions are being tested in trial NCT02508662?
The interventions under investigation include: Review of Screening Tests and Molecular Test Results (OTHER).
Who is sponsoring clinical trial NCT02508662?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.